← Leaderboards
Kevin Clayton
Boston University Medical Campus
$135,060
Attributed
$135,060
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45.5K · FY2018–20$50K$37.5K$25K$12.5K$0
'18
'19
'20
Funding mix
By agency
NIH$135,060 · 1
By mechanism
F31$135,060 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Alpaslan Dedeoglu$7,018,151
- H Scott Swartzwelder$9,953,856
- Jan Krzysztof Blusztajn$11,412,004
- Benjamin L Wolozin$31,159,035
- Jose Rafael Romero$5,806,073
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposChronicAutopsyAgonistCellsAcuteAmyloid Beta-ProteinAmyloid Beta-Protein PrecursorAnimal ModelAntibodiesC57bl/6 MouseAbeta ClearanceAppearanceAreaAge-Associated Memory ImpairmentAxonBaseBehavioralBehavioral AssayBiochemistryBiological AvailabilityBody WeightAbeta OligomerClinical Candidate
Grant awards (3)
TREM2-TYROBP coupling modulation for the reduction of Alzheimer's-mediated neuroinflammation: a novel pharmacologic therapy$45,520
F31 · FY2020 · AG · contact PI
TREM2-TYROBP coupling modulation for the reduction of Alzheimer's-mediated neuroinflammation: a novel pharmacologic therapy$45,016
F31 · FY2019 · AG · contact PI
TREM2-TYROBP coupling modulation for the reduction of Alzheimer's-mediated neuroinflammation: a novel pharmacologic therapy$44,524
F31 · FY2018 · AG · contact PI